Skip to content
value.today

Renovaro Inc. is listed today as Lunai Bioworks Inc.: market value, financials and filings are on its company page.

Funding rounds

0 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Renovaro Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2024$107 MPrivate placement after listing$50 to $250 million

Renovaro Inc.: Private sale, Feb 2024

Investors in this round

8 investors had bought by the notice of Feb 23, 2024: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$107 M of $107 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Francois Binette · Executive Officer
  • Luisa Puche · Executive Officer
  • Mark Dybul · Executive Officer, Director
  • Avram Miller · Director
  • Carol Brosgart · Director
  • Gregg Alton · Director
  • James Sapirstein · Director
  • Jayne McNicol · Director
  • Karen Brink · Director
  • Leni Boeren · Director
  • Rene Sindlev · Director
  • Ruud Hendriks · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On a merger: “Issuance of common stock as a portion of consideration payable in exchange for outstanding equity interests of GEDi Cube Intl Ltd.”

Signed by Mark Dybul, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 23, 2024. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Renovaro Inc. had no revenue when it filed its newest notice of a funding round (Feb 2024).

    SEC Form D (revenue range) · Feb 2024

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Feb 2024

Products and services#

No products or services of Renovaro Inc. are on record.

Investors#

No investor of Renovaro Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.

Largest shareholders today

Institutions holding Lunai Bioworks Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Renovaro Inc.
NameRoleNamed in
Francois BinetteExecutive officerFeb 2024
Luisa PucheExecutive officerFeb 2024
Mark DybulExecutive officerFeb 2024
Avram MillerDirectorFeb 2024
Carol BrosgartDirectorFeb 2024
Gregg AltonDirectorFeb 2024
James SapirsteinDirectorFeb 2024
Jayne McNicolDirectorFeb 2024
Karen BrinkDirectorFeb 2024
Leni BoerenDirectorFeb 2024
Mark DybulDirectorFeb 2024
Rene SindlevDirectorFeb 2024
Ruud HendriksDirectorFeb 2024

Went public since 2013. Its SEC number is that of a company listed on a stock exchange.